Can a common ectopic pregnancy drug work in women with kidney or liver issues?
NCT ID NCT07186127
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study reviews medical records of 230 women treated with methotrexate for ectopic pregnancy, focusing on those with conditions that usually make this drug risky, like kidney or liver problems. Researchers will check how well the treatment worked by measuring pregnancy hormone levels and whether surgery was needed. The goal is to gather real-world data to help doctors make better decisions for similar patients in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Methotrexate
What this could lead to
If successful, this study could help doctors understand when it is safe to use methotrexate for ectopic pregnancy in women with kidney or liver issues.
What could go wrong
This is a retrospective study, meaning it looks back at old records, not a controlled trial. Results may not apply to all patients, and the study cannot prove cause and effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ECTOPIC PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Health Sciences, Training and Research Hospital
RECRUITINGIstanbul, Türkiye, 34200, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••